In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012-2019

Jean, Shio-ShinShio-ShinJeanLee, Yu-LinYu-LinLeeHsu, Chin-WangChin-WangHsuPO-REN HSUEH2022-09-212022-09-212022-0909248579https://scholars.lib.ntu.edu.tw/handle/123456789/621806A total of 74 570 potentially naturally inducible chromosomal AmpC-producing (PNIC-AmpC) Enterobacterales isolates included in the Antimicrobial Testing Leadership and Surveillance Programme were obtained worldwide during 2012-2019 (22 503 from 2012-2014 and 52 067 from 2015-2019). Of these isolates, 117 and 711 obtained during 2012-2014 and 2015-2019, respectively, were carbapenem-resistant Enterobacterales (PNIC-AmpC-CRE). The MICs of ceftazidime-avibactam for these isolates were determined using the broth microdilution method.enCarbapenem-resistant Enterobacterales; Ceftazidime-avibactam; Metallo-β-lactamase; Potentially naturally inducible chromosomal (PNIC) AmpC-producers; Resistance[SDGs]SDG3In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012-2019journal article10.1016/j.ijantimicag.2022.106617357182662-s2.0-85134821134https://api.elsevier.com/content/abstract/scopus_id/85134821134